James Christensen

Biocom California recently invited Sapient to contribute an article for its Lifelines Magazine edition focused on innovations in #genetherapy and #celltherapy. https://lnkd.in/gC9YfQnM While cell- and gene-based treatments are advancing rapidly, spurred by a landmark year of FDA approvals, their development is not without challenges. We discuss how #multiomics for gene and cell therapy can deliver the novel insights needed to realize the incredible therapeutic potential represented in these pipelines today: https://lnkd.in/gC9YfQnM

21

#ICYMI: Last month we announced that we raised $132.5 million in an oversubscribed #SeriesC financing to advance our pipeline of potential therapies for fibrotic lung diseases and oncology. We are thankful for the support of our investors, board, #biotech community and the entire Endeavor BioMedicines team.     In this BioSpace article, get more details about what this financing means for the future of our pipeline and our goal to restore hope for patients with life-threatening diseases: https://bit.ly/4aVqAmo    #biotechnews #fundraising #venturecapital #oncology #lungdiseases

51

Recognizing the signs and symptoms of chronic myeloid leukemia (CML) is essential for effective management. Early detection and understanding of key indicators play a crucial role in creating appropriate treatment strategies and improving outcomes for individuals with CML. Learn more about CML from the American Cancer Society at https://lnkd.in/eZfjAhe2 #CancerResearch #CancerResearchMonth #NCRM24

3

Personalized neoantigen specific TCR gene therapy

7

Check out this excellent review article by Lotze, Olejniczak and Skokos in Nature Reviews Immunology! Over the last 5 years there has been a renaissance in evaluating CD28 bispecific antibodies as novel cancer immunotherapies. In this review they shed light on the basic biology of CD28 signaling but also it’s regulation and control in the tumor microenvironment aswell as the current development of therapeutic targeted CD28 agonists as new anti cancer therapies. https://lnkd.in/ezhJUXqx

135

Come see us in San Diego for the RNA Leaders USA Congress! Today, our CEO Nathaniel Wang will discuss scaling strategies for #RNAtherapies during a keynote panel before presenting on key improvements enabled by our #srRNA technology in the afternoon. #RNALeaders #biotech #mRNA #RNA #vaccine

30

🎧 Check out the Mendelspod podcast episode, "Two Industry Leaders on Dealing with the Growing Complexity of Genomic Cancer Data," featuring JAX's Cara Statz & Illumina's Erica Schnettler discussing the landscape of oncology research, oncology testing and variant interpretation:

2

Latest on MDMA rejection; Novo vs. Lilly earnings; Recursion, Exscientia to merge; Q&A with Genentech CEO; and more https://lnkd.in/gRuf3XRp Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News

1